FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Releases Guidances on Generic Topical Drugs

FDA posts three FDA draft guidances that provide general recommendations for physicochemical and structural characterization tests, in vitro release t...

latest-news-card-1
FDA General

Paper Calls for FDA Reforms on Transparency/Evidence

A white paper commissioned by Georgetown University says changes are needed at FDA because its evidence standards have become distorted, which have le...

latest-news-card-1
Medical Devices

Medtronic Pacing Lead Gets Expanded Labeling

FDA approves expanded labeling on Medtronics SelectSecure MRI SureScan Model 3830 cardiac lead for conduction system pacing.

latest-news-card-1
Federal Register

Real-World Evidence Program Announced

Federal Register notice: FDA announces the Advancing Real-World Evidence (RWE) Program, which was agreed to under the recent user fee reauthorization....

latest-news-card-1
Human Drugs

PhRMA Raises QMM, KASA Issues

PhRMA raises issues about the CDER Quality Management Maturity and Knowledge-Aided Assessment and Structured Application programs to be considered by ...

latest-news-card-1
Federal Register

Comments Extended on Animal Generic User Fees

Federal Register notice: FDA extends the comment period associated with a 9/30 notice on the proposed recommendations for the reauthorization of the A...

latest-news-card-1
Federal Register

Guide on GMPs for Animal Cell/Tissue Products

Federal Register notice: FDA makes available a final guidance #253 entitled Current Good Manufacturing Practice for Animal Cells, Tissues, and Cell- a...

latest-news-card-1
Human Drugs

Multiple Clinical Trial Endpoints Guidance

FDA publishes a guidance on accounting for multiple endpoints in the analysis of drug and biologic clinical trials.

latest-news-card-1
Human Drugs

Talaris Reports FREEDOM-1 Study Death

Talaris says it has informed FDA about the death of a subject in the FREEDOM-1 trial of FCR001 in live donor kidney transplant recipients.

latest-news-card-1
Human Drugs

ImClone Systems FDA-483

FDA releases the form FDA-483 with two observations from an inspection at Branchburg, NJ-based ImClone Systems.